Standard binding and functional assays related to medications development division testing for potential cocaine and opiate narcotic treatment medications - PubMed

Affiliations

• PMID: 9686407

Standard binding and functional assays related to medications development division testing for potential cocaine and opiate narcotic treatment medications

L Toll et al. NIDA Res Monogr. 1998 Mar.

Similar articles

• Evaluation of new compounds for opioid activity (1983).

  Woods JH, Winger GD, Medzihradsky F, Smith CB, Katz JL. Woods JH, et al. NIDA Res Monogr. 1984 Mar;49:361-7. NIDA Res Monogr. 1984. PMID: 6090918 No abstract available.

• The synthesis and pharmacological activity of two new derivatives of benzazocine.

  Gutkowska B, Gumułka SW, Krzaścik P, Poppe I, Mészáros J, Makulska HE. Gutkowska B, et al. Pol J Pharmacol Pharm. 1991 Mar-Apr;43(2):153-63. Pol J Pharmacol Pharm. 1991. PMID: 1658757

• Cocaine, dopamine and the endogenous opioid system.

  Kreek MJ. Kreek MJ. J Addict Dis. 1996;15(4):73-96. doi: 10.1300/J069v15n04_05. J Addict Dis. 1996. PMID: 8943583 Review.

• Testing and evaluation of opiate analgesics and antagonists.

  Hahn EF. Hahn EF. Methods Find Exp Clin Pharmacol. 1985 Jul;7(7):373-81. Methods Find Exp Clin Pharmacol. 1985. PMID: 2865415

• Genetic determinants of addiction to opioids and cocaine.

  Saxon AJ, Oreskovich MR, Brkanac Z. Saxon AJ, et al. Harv Rev Psychiatry. 2005 Jul-Aug;13(4):218-32. doi: 10.1080/10673220500243364. Harv Rev Psychiatry. 2005. PMID: 16126608 Review.

Cited by

• Photoactivatable neuropeptides for spatiotemporally precise delivery of opioids in neural tissue.

  Banghart MR, Sabatini BL. Banghart MR, et al. Neuron. 2012 Jan 26;73(2):249-59. doi: 10.1016/j.neuron.2011.11.016. Neuron. 2012. PMID: 22284180 Free PMC article.

• Characterization of kappa opioid receptor mediated, dynorphin-stimulated [35S]GTPγS binding in mouse striatum for the evaluation of selective KOR ligands in an endogenous setting.

  Zhou L, Stahl EL, Lovell KM, Frankowski KJ, Prisinzano TE, Aubé J, Bohn LM. Zhou L, et al. Neuropharmacology. 2015 Dec;99:131-41. doi: 10.1016/j.neuropharm.2015.07.001. Epub 2015 Jul 6. Neuropharmacology. 2015. PMID: 26160155 Free PMC article.

• The Effects of Pharmacological Opioid Blockade on Neural Measures of Drug Cue-Reactivity in Humans.

  Courtney KE, Ghahremani DG, Ray LA. Courtney KE, et al. Neuropsychopharmacology. 2016 Nov;41(12):2872-2881. doi: 10.1038/npp.2016.99. Epub 2016 Jun 17. Neuropsychopharmacology. 2016. PMID: 27312405 Free PMC article. Clinical Trial.

• Imaging cortical dopamine D1 receptors using [11C]NNC112 and ketanserin blockade of the 5-HT 2A receptors.

  Catafau AM, Searle GE, Bullich S, Gunn RN, Rabiner EA, Herance R, Radua J, Farre M, Laruelle M. Catafau AM, et al. J Cereb Blood Flow Metab. 2010 May;30(5):985-93. doi: 10.1038/jcbfm.2009.269. Epub 2009 Dec 23. J Cereb Blood Flow Metab. 2010. PMID: 20029452 Free PMC article.

• Activities of mixed NOP and mu-opioid receptor ligands.

  Spagnolo B, Calo G, Polgar WE, Jiang F, Olsen CM, Berzetei-Gurske I, Khroyan TV, Husbands SM, Lewis JW, Toll L, Zaveri NT. Spagnolo B, et al. Br J Pharmacol. 2008 Feb;153(3):609-19. doi: 10.1038/sj.bjp.0707598. Epub 2007 Dec 3. Br J Pharmacol. 2008. PMID: 18059322 Free PMC article.

MeSH terms

Substances

LinkOut - more resources

• Other Literature Sources

  • The Lens - Patent Citations Database

• Chemical Information

  • BindingDB

• Medical

  • MedlinePlus Consumer Health Information
  • MedlinePlus Health Information

• Molecular Biology Databases

  • Guide to Pharmacology